Filing Details

Accession Number:
0001035267-25-000198
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-07-29 13:02:33
Reporting Period:
2025-07-28
Filing Date:
2025-07-29
Accepted Time:
2025-07-29 13:02:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1035267 Intuitive Surgical Inc ISRG Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 770416458
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1280628 S Gary Guthart 1020 Kifer Road
Sunnyvale CA 94086
Executive Chair Of The Board O Yes Yes No No
Transaction Summary
Sold: 10,693 shares Avg. Price: $497.75 Total Value: $5,322,418.81
Number of Shares After Transactions: 1,204,863 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-07-28 7,893 $59.46 21,080 No 4 M Direct
Common Stock Disposition 2025-07-28 7,893 $498.64 13,187 No 4 S Direct
Common Stock Disposition 2025-07-28 1,400 $495.23 18,520 No 4 S Indirect Trust FBO Daughter
Common Stock Disposition 2025-07-28 1,400 $495.24 18,520 No 4 S Indirect Trust FBO Son
Common Stock Disposition 2025-07-28 10,500 $0.00 1,204,863 No 4 G Indirect by Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Indirect Trust FBO Daughter
No 4 S Indirect Trust FBO Son
No 4 G Indirect by Trust
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2025-07-28 7,893 $0.00 7,893 $59.46
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2026-02-16 No 4 M Direct
Footnotes
  1. The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on April 28, 2026.
  2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $494.33 to $500.00 as follows: 475 shares sold at $494.33 to $495.16; 202 shares sold at $495.79 to $496.62; 1,045 shares sold at $496.81 to $496.87; 1,996 shares sold at $498.06 to $499.00; and 4,175 shares sold at $499.20 to $500.00. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  3. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $493.85 to $496.31 as follows: 527 shares sold at $493.85 to $494.81; 569 shares sold at $494.97 to $495.72; and 304 shares sold at $496.00 to $496.31. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  4. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $493.85 to $496.31 as follows: 320 shares sold at $493.85 to $494.85; 806 shares sold at $494.87 to $495.62; and 274 shares sold at $496.00 to $496.31. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  5. The shares were donated to a Donor Advised Fund (DAF) in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on April 28, 2026.
  6. Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.